Latest News
Bain Capital and Parthenon Capital are in discussions to sell a minority stake in healthcare technology company Zelis in a deal that could value the firm at around $17bn, according to a report by Bloomberg.
US private equity major TPG is in discussions to acquire a stake in Europe’s largest second-hand fashion platform, Vinted, at a valuation of €5bn following rapid expansion at the Lithuanian company, according to a report by the Financial Times.
BEX Capital, a private investment firm focused exclusively on secondaries in private equity fund-of-funds (FoF), secondaries funds and co-investment funds, has held the final close of BEX Fund V at its target of $765m in capital commitments.
Global private equity firm Permira’s Growth Opportunities II, fund has acquired a majority stake in BioCatch, a specialist in digital fraud detection and financial crime prevention powered by behavioural biometric intelligence.
FalconPoint Partners (FalconPoint), a private equity firm focused on investing in North American middle market companies in the business services and industrial sectors, has appointed Adam Gross as Partner, Head of Business Development and Capital Markets.
CIL, the growth strategy consulting firm with offices in the US, Europe, and the UK, has hired Frédéric Thomas as Partner to lead its French operations, and be part of its Global Healthcare & Life Sciences practice.
Amulet Capital Partners, a middle-market private equity investment firm focused exclusively on investments in the healthcare sector, has appointed Michael Keaveney as a Partner and Head of Investor Relations.
Swedish private investment firm EQT has agreed to acquire a controlling stake in GeBBS, a global provider of healthcare outsourcing solutions, from ChrysCapital. While financial terms of the deal have not been disclosed, reports suggest a purchase price of over $850m.
European private equity investment firm Castik Capital has held the final close of its third fund, EPIC III, with total capital commitments of €2bnm exceeding its target of €1.75bn . The fund is 60% larger than predecessor EPIC II, which closed at €1.25bn in October 2020.
Virginie Morgon, former CEO of Eurazeo SE and one of the most prominent figures in European private equity, is setting up her own private equity firm with a strong focus on sustainable investments, according to a report by Bloomberg.
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
